These investigators noted that the effect of TAB1 signaling was specific to the TAB1α splicing product of the TAB1 gene located on chromosome 22, which has also been linked to systemic sclerosis and type 2 diabetes, hinting at a potential genetic component involving TAB1 mutation in the initiation of these diseases. This evidence concerns the gene TAB1 and type 2 diabetes mellitus.